Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study

Summary Background The model of infectious disease prevention and control changed significantly in China after the outbreak in 2003 of severe acute respiratory syndrome (SARS), but trends and epidemiological features of infectious diseases are rarely studied. In this study, we aimed to assess specific incidence and mortality trends of 45 notifiable infectious diseases from 2004 to 2013 in China and to investigate the overall effectiveness of current prevention and control strategies. Methods Incidence and mortality data for 45 notifiable infectious diseases were extracted from a WChinese public health science data centre from 2004 to 2013, which covers 31 provinces in mainland China. We estimated the annual percentage change in incidence of each infectious disease using joinpoint regression. Findings Between January, 2004, and December, 2013, 54 984 661 cases of 45 infectious diseases were reported (average yearly incidence 417·98 per 100 000). The infectious diseases with the highest yearly incidence were hand, foot, and mouth disease (114·48 per 100 000), hepatitis B (81·57 per 100 000), and tuberculosis (80·33 per 100 000). 132 681 deaths were reported among the 54 984 661 cases (average yearly mortality 1·01 deaths per 100 000; average case fatality 2·4 per 1000). Overall yearly incidence of infectious disease was higher among males than females and was highest among children younger than 10 years. Overall yearly mortality was higher among males than females older than 20 years and highest among individuals older than 80 years. Average yearly incidence rose from 300·54 per 100 000 in 2004 to 483·63 per 100 000 in 2013 (annual percentage change 5·9%); hydatid disease (echinococcosis), hepatitis C, and syphilis showed the fastest growth. The overall increasing trend changed after 2009, and the annual percentage change in incidence of infectious disease in 2009–13 (2·3%) was significantly lower than in 2004–08 (6·2%). Interpretation Although the overall incidence of infectious diseases was increasing from 2004, the rate levelled off after 2009. Effective prevention and control strategies are needed for diseases with the highest incidence—including hand, foot, and mouth disease, hepatitis B, and tuberculosis—and those with the fastest rates of increase (including hydatid disease, hepatitis C, and syphilis). Funding Chinese Ministry of Science and Technology, National Natural Science Foundation (China).

[1]  Wenjun Song,et al.  Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome , 2013, The Lancet.

[2]  Peng Wang,et al.  Long-term effectiveness of the integrated schistosomiasis control strategy with emphasis on infectious source control in China: a 10-year evaluation from 2005 to 2014 , 2017, Parasitology Research.

[3]  Leonhard Held,et al.  Modeling seasonality in space‐time infectious disease surveillance data , 2012, Biometrical journal. Biometrische Zeitschrift.

[4]  Yu Wang,et al.  Emergence and control of infectious diseases in China , 2008, The Lancet.

[5]  M. Tebruegge,et al.  Tuberculosis in young refugees , 2015, The Lancet.

[6]  Kate E. Jones,et al.  Global trends in emerging infectious diseases , 2008, Nature.

[7]  Shigui Yang,et al.  Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China , 2015, Scientific Reports.

[8]  Biao Xu,et al.  Tuberculosis-associated mortality in Shanghai, China: a longitudinal study , 2015, Bulletin of the World Health Organization.

[9]  Wu-Chun Cao,et al.  Dual Seasonal Patterns for Influenza, China , 2010, Emerging infectious diseases.

[10]  Weizhong Yang,et al.  An outbreak following importation of wild poliovirus in Xinjiang Uyghur Autonomous Region, China, 2011 , 2015, BMC Infectious Diseases.

[11]  K. Ji,et al.  Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9 , 2016, BioMed research international.

[12]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[13]  T. Cikač,et al.  HAND-FOOT-AND-MOUTH-DISEASE (HFMD) , 2016 .

[14]  J. Guilbert The world health report 2002 - reducing risks, promoting healthy life. , 2003, Education for health.

[15]  V. Isham,et al.  Modeling infectious disease dynamics in the complex landscape of global health , 2015, Science.

[16]  Yonghong Xiao,et al.  Antiviral Therapy and Outcomes of Patients with Pneumonia Caused by Influenza A Pandemic (H1N1) Virus , 2012, PloS one.

[17]  K. Shaw The 2003 SARS outbreak and its impact on infection control practices , 2005, Public Health.

[18]  Shawn T. Brown,et al.  Contagious diseases in the United States from 1888 to the present. , 2013, The New England journal of medicine.

[19]  Guilbert Jj The world health report 2002 - reducing risks, promoting healthy life. , 2003 .